Article
ALDH1A2 (RALDH2) genetic variation in human congenital heart disease.
BMC medical genetics - 3 Nov 2009
Pavan Marilene, Ruiz Viviane F, Silva Fábio A, Sobreira Tiago J, Cravo Roberta M, Vasconcelos Michelle, Marques Lívia P, Mesquita Sonia M F, Krieger José E, Lopes Antônio A B, Oliveira Paulo S, Pereira Alexandre C, Xavier-Neto José
Abstract excerpt
BACKGROUND: Signaling by the vitamin A-derived morphogen retinoic acid (RA) is required at multiple steps of cardiac development. Since conversion of retinaldehyde to RA by retinaldehyde dehydrogenase type II (ALDH1A2, a.k.a RALDH2) is critical for cardiac development, we screened patients with congenital heart disease (CHDs) for genetic variation at the ALDH1A2 locus. METHODS: One-hundred and thirty-three CHD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
